Cargando…
A Case of Autoimmune Polyglandular Syndrome .ype 2 Associated with Atypical Form of Scleromyxedema
BACKGROUND: Autoimmune polyglandular syndrome type 2 represents an uncommon endocrine disorder composed by Addison's disease with autoimmune thyroid disease (Schmidt's syndrome) and/or type 1 diabetes mellitus. Scleromyxedema is a rare progressive cutaneous mucinosis usually associated wit...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Research and Publications Office of Jimma University
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5389067/ https://www.ncbi.nlm.nih.gov/pubmed/28446858 |
_version_ | 1782521223445479424 |
---|---|
author | Prylutskyi, Oleksander Prylutska, Olga Degonskyi, Anatoliy Tkachenko, Kseniia |
author_facet | Prylutskyi, Oleksander Prylutska, Olga Degonskyi, Anatoliy Tkachenko, Kseniia |
author_sort | Prylutskyi, Oleksander |
collection | PubMed |
description | BACKGROUND: Autoimmune polyglandular syndrome type 2 represents an uncommon endocrine disorder composed by Addison's disease with autoimmune thyroid disease (Schmidt's syndrome) and/or type 1 diabetes mellitus. Scleromyxedema is a rare progressive cutaneous mucinosis usually associated with systemic involvement and paraproteinemia. To the best of our knowledge, there is no case report of Schmidt's syndrome associated with scleromyxedema. CASE DETAILS: A 34-year-old woman was admitted to Donetsk Clinical Territorial Medical Association due to acute general weakness, reduced vision, dryness of integuments, memory decline, fatigue, weight loss, rash on the face trunk and extremities. A diagnosis of APS type II was made comprising of autoimmune hypothyroidism and autoimmune adrenal insufficiency. Skin histopathologic examination demonstrated the presence of mucin deposits, dermal fibrosis, fibrocytes and perivascular inflammation. In the absence of monoclonal paraproteinemia and the presence of typical histological and clinical signs, an atypical form of scleromyxedema was diagnosed. The patient was administered a lifetime replacement levothyroxine and methylprednisolone therapy. CONCLUSION: Identification and adequate treatment of both APS type II and scleromyxedema in affected patients pose a problem due to the lack of facilities for diagnosis and management plus common misdiagnosis. Early diagnosis should be made before the development of life-threatening complications. |
format | Online Article Text |
id | pubmed-5389067 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Research and Publications Office of Jimma University |
record_format | MEDLINE/PubMed |
spelling | pubmed-53890672017-04-26 A Case of Autoimmune Polyglandular Syndrome .ype 2 Associated with Atypical Form of Scleromyxedema Prylutskyi, Oleksander Prylutska, Olga Degonskyi, Anatoliy Tkachenko, Kseniia Ethiop J Health Sci Case Report BACKGROUND: Autoimmune polyglandular syndrome type 2 represents an uncommon endocrine disorder composed by Addison's disease with autoimmune thyroid disease (Schmidt's syndrome) and/or type 1 diabetes mellitus. Scleromyxedema is a rare progressive cutaneous mucinosis usually associated with systemic involvement and paraproteinemia. To the best of our knowledge, there is no case report of Schmidt's syndrome associated with scleromyxedema. CASE DETAILS: A 34-year-old woman was admitted to Donetsk Clinical Territorial Medical Association due to acute general weakness, reduced vision, dryness of integuments, memory decline, fatigue, weight loss, rash on the face trunk and extremities. A diagnosis of APS type II was made comprising of autoimmune hypothyroidism and autoimmune adrenal insufficiency. Skin histopathologic examination demonstrated the presence of mucin deposits, dermal fibrosis, fibrocytes and perivascular inflammation. In the absence of monoclonal paraproteinemia and the presence of typical histological and clinical signs, an atypical form of scleromyxedema was diagnosed. The patient was administered a lifetime replacement levothyroxine and methylprednisolone therapy. CONCLUSION: Identification and adequate treatment of both APS type II and scleromyxedema in affected patients pose a problem due to the lack of facilities for diagnosis and management plus common misdiagnosis. Early diagnosis should be made before the development of life-threatening complications. Research and Publications Office of Jimma University 2016-09 /pmc/articles/PMC5389067/ /pubmed/28446858 Text en Copyright © Jimma University, Research & Publications Office 2016 |
spellingShingle | Case Report Prylutskyi, Oleksander Prylutska, Olga Degonskyi, Anatoliy Tkachenko, Kseniia A Case of Autoimmune Polyglandular Syndrome .ype 2 Associated with Atypical Form of Scleromyxedema |
title | A Case of Autoimmune Polyglandular Syndrome .ype 2 Associated with Atypical Form of Scleromyxedema |
title_full | A Case of Autoimmune Polyglandular Syndrome .ype 2 Associated with Atypical Form of Scleromyxedema |
title_fullStr | A Case of Autoimmune Polyglandular Syndrome .ype 2 Associated with Atypical Form of Scleromyxedema |
title_full_unstemmed | A Case of Autoimmune Polyglandular Syndrome .ype 2 Associated with Atypical Form of Scleromyxedema |
title_short | A Case of Autoimmune Polyglandular Syndrome .ype 2 Associated with Atypical Form of Scleromyxedema |
title_sort | case of autoimmune polyglandular syndrome .ype 2 associated with atypical form of scleromyxedema |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5389067/ https://www.ncbi.nlm.nih.gov/pubmed/28446858 |
work_keys_str_mv | AT prylutskyioleksander acaseofautoimmunepolyglandularsyndromeype2associatedwithatypicalformofscleromyxedema AT prylutskaolga acaseofautoimmunepolyglandularsyndromeype2associatedwithatypicalformofscleromyxedema AT degonskyianatoliy acaseofautoimmunepolyglandularsyndromeype2associatedwithatypicalformofscleromyxedema AT tkachenkokseniia acaseofautoimmunepolyglandularsyndromeype2associatedwithatypicalformofscleromyxedema AT prylutskyioleksander caseofautoimmunepolyglandularsyndromeype2associatedwithatypicalformofscleromyxedema AT prylutskaolga caseofautoimmunepolyglandularsyndromeype2associatedwithatypicalformofscleromyxedema AT degonskyianatoliy caseofautoimmunepolyglandularsyndromeype2associatedwithatypicalformofscleromyxedema AT tkachenkokseniia caseofautoimmunepolyglandularsyndromeype2associatedwithatypicalformofscleromyxedema |